Geraint said: “I was diagnosed with multiple myeloma following a fall on a golf course. The treatment I’ve received at the Leri Day Unit since has been second to none. “My treatment necessitated a ...
Investor's Business Daily on MSN1h
Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple MyelomaLegend Biotech said Friday its cancer drug, Carvykti, lowered the risk of death by 45% in a study of multiple myeloma patients.
Poseida’s partnerships with Roche and Astellas aim to advance CAR-T therapies. See PSTX stock details and the impact of ...
Johnson & Johnson has reported Phase III data where CARVYKTI improved overall survival in patients with multiple myeloma.
After putting on a strong performance in preventing disease progression in the earlier treatment of multiple myeloma, Johnson ...
Johnson & Johnson and Legend Biotech presented new data from the Phase 3 CARTITUDE-4 study, showing Carvykti significantly ...
Boris Johnson's decision to reveal the late monarch's diagnosis is likely to raise eyebrows at Buckingham Palace.
Johnson & Johnson linked Carvykti to a 45% reduction in risk of death and Darzalex to a 61% improvement in minimal residual ...
Adding daratumumab to lenalidomide in maintenance therapy for multiple myeloma significantly reduced rates of minimal ...
FOX 5 Washington DC on MSN1d
Marching towards a cure for Multiple MyelomaMore than 200 people were reported rescued from floodwaters in North Carolina following Helene’s torrential rains with more ...
A new CAR T-cell therapy, durcabtagene autoleucel, showed promising results in treating relapsed/refractory multiple myeloma ...
A benefit for local musician and worship pastor Chris Robbins will be held at the Friedhof Building Sunday, Sept. 29, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback